Navigation Links
Cardiac Science Sets Date for Fourth Quarter, Year-End Results Release and Conference Call
Date:3/3/2010

BOTHELL, Wash., March 3 /PRNewswire-FirstCall/ Cardiac Science Corporation (Nasdaq: CSCX), a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, announced today that it will release its fourth quarter 2009 financial results on Thursday, March 11, 2010 after market close. The Company has scheduled a conference call with analysts and investors for 4:30 p.m. Eastern Time. During the call, Cardiac Science management will discuss the financial results for the fourth quarter as well as the current business outlook.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080306/AQTH510LOGO)

To access the conference call, please dial 888.549.7880 and reference conference ID 4252130. Callers outside the U.S. can dial 480.629.9868. The call will also be webcast live at www.cardiacscience.com. An audio replay of the call will be available for 7 days following the call at 800.406.7325 for U.S. callers or 303.590.3030 for those calling from outside the U.S. The password required to access the replay is 4252130#. An archived webcast will also be available at www.cardiacscience.com for 90 days.

About Cardiac Science

Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AED), electrocardiograph devices (ECG/EKG), cardiac stress treadmill and systems, Holter monitoring systems, hospital defibrillators, vital signs monitors, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The company sells a variety of related products and consumables and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick(R), HeartCentrix(R), Powerheart(R), and Quinton(R) brands, is headquartered in Bothell, Washington. With customers in more than 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://www.cardiacscience.com.

For updates and information on worldwide defibrillation and cardiac monitoring, find us on the Cardiac Science blog at http://www.cardiacscience.com/blog, Twitter at http://twitter.com/cardiacscience, Facebook at http://budurl.com/CSonFB, and YouTube at http://budurl.com/CSonYT.


     For more information,
     Company Contact:                  Investor Contact:
     Mike Matysik                      Matt Clawson
     Cardiac Science Corporation       Allen & Caron
     Senior Vice President and CFO     949.474.4300
     425.402.2009                      matt@allencaron.com

     Media Contact:
     Christopher Gale
     EVC Group Inc.
     646.201.5431
     203.570.4681
     cgale@evcgroup.com


    LOGO: http://www.cardiacscience.com/images/main_logo.gif

CSCX-F

SOURCE Cardiac Science Corporation

Back to top

RELATED LINKS
http://www.cardiacscience.com

'/>"/>

SOURCE Cardiac Science Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. New cardiac CT technology drastically reduces patient radiation exposure
2. Pluromed Announces Completion of Enrollment in LeGoo™ Cardiac Bypass Clinical Trial
3. Herbal Remedies Can Cause Cardiac Problems
4. Sudden Cardiac Arrest Foundation Launches First Virtual Affiliate
5. Study Questions FDA Approvals of Cardiac Devices
6. With Cardiac Rehab, More Is Better: Study
7. Study finds gender gap persists in cardiac care
8. Cooling may benefit children after cardiac arrest
9. Inhibition of GRK2 is protective against acute cardiac stress injuries
10. Resuscitation and Survival Rates from Out-of-Hospital Cardiac Arrest Nearly Double with Comprehensive Treatment Protocol
11. Resuscitation and survival rates from out-of-hospital cardiac arrest nearly double
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... ... February 17, 2017 , ... Corrective Action & Preventive ... FDAnews Webinar**, Feb. 23, 2017 — 1:30 p.m. – 3:00 p.m. ET, ... and preventive action (PA)? , The methods share techniques and tools but they ...
(Date:2/17/2017)... , ... February 17, 2017 , ... ... management services, announced today that Karen Pilley has been promoted to Chief Executive ... in today’s shifting healthcare paradigm – a shift that demands the transition from ...
(Date:2/17/2017)... ... ... Like most hospitals across the nation, Onslow Memorial Hospital is looking for more ... Program (HRRP), the return of a patient to the hospital within 30 days of ... providers are struggling to leverage limited resources and technology, Onslow Memorial Hospital has saved ...
(Date:2/16/2017)... ... February 17, 2017 , ... Harsha Chigurupati ... years of research, development and clinical trials, the founder of Chigurupati Technologies has ... compound of FDA approved ingredients that when infused into alcohol, protect the consumer’s ...
(Date:2/16/2017)... Kisco, New York (PRWEB) , ... February 16, ... ... Hospital’s (NWH) nursing professionalism, teamwork and superiority in patient care, NWH has ... of the Commission on Magnet on Tuesday, January 31, 2017. The American Nurses ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... 2017  Ethicon, Inc. today announced a definitive ... held medical device company that manufactures and markets ... novel minimally invasive device for the surgical treatment ... enable Ethicon to offer patients a safe and ... surgical procedure. 1 This LINX ...
(Date:2/17/2017)...  Perrigo Company plc (NYSE, TASE: PRGO) today announced it ... Administration for hydrocodone bitartrate and homatropine methylbromide oral solution (syrup), ... bitartrate and homatropine methylbromide oral solution (syrup), 5 mg/1.5 mg ... cough in adults and children 6 years of age and ... were approximately $16 million.   ...
(Date:2/17/2017)... partnership with CitiHope , Panexus Haiti ... Jack Brewer Foundation (JBF Worldwide) has sent a ... medicine to Innovating Health International (IHI) in ... to treating chronic diseases and addressing women,s health issues in developing ... and providing these medicines to the organization ...
Breaking Medicine Technology: